GILEAD SCIENCES, INC.

Gilead Sciences (GILD) shows zero cyber incidents and zero red-flag 8-K filings in our 90-day monitoring window, indicating a clean recent compliance record. However, low signal in this short timeframe does not establish low forward risk; the company operates in biotech where financing structures and equity dilution patterns carry material weight. The full $49 Report extends analysis to 12 months of SEC filings, calculates dilution risk scores, maps financing history, and surfaces AI-flagged risk signals across officer changes and derivative securities activity. The full $49 Report adds quantified dilution exposure, 8-K context over a full fiscal cycle, and machine-scored early warning indicators across the capital structure.